Mustang Bio, Inc. announced that it will receive $4,742,942 in funding on October 26, 2023. The company will issue convertible preferred stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 USD | +1.38% | -27.40% | -83.22% |
05-15 | Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.22% | 2.7M | |
+12.15% | 116B | |
+12.52% | 106B | |
-9.08% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.44% | 16.33B | |
+6.11% | 14.14B | |
+28.91% | 12.02B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Mustang Bio, Inc. announced that it expects to receive $4.742942 million in funding